NASDAQ: APLMW - Apollomics, Inc.

Rentabilité sur six mois: -53.08%

Calendrier des promotions Apollomics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc.

Plus de détails
was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

EBITDA -0.0742
EV/EBITDA 1.76
IPO date 2021-11-26
Industry Biotechnology
P/BV 0.0543
P/S 2.27
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0018
Цена ао 0.026
Число акций ао 0.0895 млрд
Changement de prix par jour: -0% (0.0122)
Changement de prix par semaine: -53.08% (0.026)
Changement de prix par mois: +41.86% (0.0086)
Changement de prix sur 3 mois: -53.08% (0.026)
Changement de prix sur six mois: -53.08% (0.026)
Changement de prix par an: -75.6% (0.05)
Evolution des prix depuis le début de l'année: -39% (0.02)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 2.27 6
P/BV 0.0451 10
P/E 0 0
EV/EBITDA 0.4657 10
Total: 5.75

Efficacité

Nom Signification Grade
ROA, % -311.63 0
ROE, % -418.59 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.085 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % -55.33 0
Rentabilité Ebitda, % -26.1 0
Rentabilité EPS, % 169.14 10
Total: 4
Plus de détails

Établissements Volume Partager, %
Ehp Funds Inc. 498450 4.82
Warberg Asset Management LLC 445600 4.31
Walleye Capital LLC 383744 3.71
BOOTHBAY FUND MANAGEMENT, LLC 373715 3.61
Yakira Capital Management, Inc. 362364 3.5
Shaw D.E. & Co., Inc. 318530 3.08
Context Capital Management, LLC 298500 2.88
MMCAP International, Inc. SPC 250000 2.42
Walleye Trading LLC 215856 2.09
Whitebox Advisors, LLC 200000 1.93

Adresse: , , - ouvrir dans Google Maps, ouvrir les cartes Yandex